tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Corona

Novavax: Street Underestimating Anticipated Strong Q2 and Outlook, Says Analyst
CoronaNovavax: Street Underestimating Anticipated Strong Q2 and Outlook, Says Analyst
3y ago
NVAX
Is Moderna Stock a Buy Following Pediatric Covid-19 Vaccine Data? Analyst Weighs In
PremiumCorona
Is Moderna Stock a Buy Following Pediatric Covid-19 Vaccine Data? Analyst Weighs In
3y ago
PFE
BNTX
Novavax: Rising Cases Could Lead to Faster Uptake of Covid-19 Vaccine
PremiumCorona
Novavax: Rising Cases Could Lead to Faster Uptake of Covid-19 Vaccine
3y ago
NVAX
Novavax: Covid-19 Vaccine Has Good Odds for EUA Approval, Says Analyst
PremiumCorona
Novavax: Covid-19 Vaccine Has Good Odds for EUA Approval, Says Analyst
3y ago
NVAX
Vaxart Stock: Awaiting Platform Validation for the Bull-Case to Kick In
PremiumCorona
Vaxart Stock: Awaiting Platform Validation for the Bull-Case to Kick In
3y ago
VXRT
In Search of a Better Covid Vaccine, This Analyst Taps Ocugen
PremiumCoronaIn Search of a Better Covid Vaccine, This Analyst Taps Ocugen
3y ago
Novavax Stock Could Hit $315, Says Analyst
Premium
Corona
Novavax Stock Could Hit $315, Says Analyst
4y ago
Is Gritstone Stock a Buy Right Now? This Is What You Need to Know
Premium
Corona
Is Gritstone Stock a Buy Right Now? This Is What You Need to Know
4y ago
Is 15% Potential Upside Good Enough to Risk Buying Inovio Stock? Analyst Weighs In
PremiumCorona
Is 15% Potential Upside Good Enough to Risk Buying Inovio Stock? Analyst Weighs In
4y ago
Why This Analyst Sees Over 80% Upside Potential for Vaxart Stock
PremiumCorona
Why This Analyst Sees Over 80% Upside Potential for Vaxart Stock
4y ago
VXRT
Moderna Stock Is Overvalued by 30%, Says JPMorgan
PremiumCorona
Moderna Stock Is Overvalued by 30%, Says JPMorgan
4y ago
Novavax: Analysts Applaud the Latest Developments
PremiumCorona
Novavax: Analysts Applaud the Latest Developments
4y ago
Ocugen’s Covid-19 Vaccine Might Have One up on mRNA Vaccines
PremiumCoronaOcugen’s Covid-19 Vaccine Might Have One up on mRNA Vaccines
4y ago
Pfizer Vaccine Less Effective on Omicron in South Africa
Premium
Corona
Pfizer Vaccine Less Effective on Omicron in South Africa
4y ago
NASDAQ
Moderna: Too Early to Tell Whether Flu Vaccine Has Differentiating Features
Premium
Corona
Moderna: Too Early to Tell Whether Flu Vaccine Has Differentiating Features
4y ago
Moderna Accelerates COVID-19 Vaccine Supply to COVAX
PremiumCorona
Moderna Accelerates COVID-19 Vaccine Supply to COVAX
4y ago
NASDAQ
Moderna Stock Dips Again; Valuation Remains Steep
PremiumCorona
Moderna Stock Dips Again; Valuation Remains Steep
4y ago
NASDAQ
AstraZeneca Lands FDA Authorization; What Next?
PremiumCorona
AstraZeneca Lands FDA Authorization; What Next?
4y ago
NASDAQ
Moderna Takes a Hit Against Omicron
PremiumCorona
Moderna Takes a Hit Against Omicron
4y ago
NASDAQ
Moderna to Supply Additional COVID-19 Vaccines to the UK
PremiumCoronaModerna to Supply Additional COVID-19 Vaccines to the UK
4y ago
NASDAQ
Novavax: Covid-19 Vaccine’s Rollout Could Play Part in Combating Omicron Variant
Premium
Corona
Novavax: Covid-19 Vaccine’s Rollout Could Play Part in Combating Omicron Variant
4y ago
Ocugen: IND Halt Not a Concern for Covaxin, Says Analyst
Premium
Corona
Ocugen: IND Halt Not a Concern for Covaxin, Says Analyst
4y ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >